VIYASHNSEViyash Scientific Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 26 Nov, 2025 · 18:31 IST

Sequent Scientific Limited has informed the Exchange that Record date for the purpose of Merger is 08-Dec-2025.

Nclt Scheme FiledStrategic Transactions View source PDFExplain this filing

VIYASH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.4%Reaction day
₹221.00
prior close
₹221.44
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.4%+2.8% vs market
Pharmaceuticals peers, median of 156sector-0.2%+2.6% vs sector

On the reaction day the stock moved 2.8 pts more than Nifty Microcap 250 and 2.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.2
10m
+1.0
15m
+1.9
30m
+5.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.4-0.4+2.8-0.2+2.6
Next day
+1.7-0.5+2.2-0.4+2.0
2d
-0.2-0.7+0.5-0.5+0.3
3d
-2.1-1.3-0.8-0.4-1.7
4d
-4.0-1.8-2.2-1.0-2.9
5d
-6.5-2.3-4.2-1.4-5.1
1w
-11.4-5.7-5.7-3.2-8.1
15d
-5.5-5.1-0.4-3.5-2.0
1m
-5.7-4.3-1.5-2.8-2.9
2m
-8.0-11.6+3.6-8.7+0.8
3m
-3.1-8.4+5.2-9.9+6.8
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Viyash Scientific Limited (formerly Sequent Scientific Limited) has announced a record date of 08-Dec-2025 for the purpose of its merger. A record date is the cut-off date set by a company to identify which shareholders are eligible to receive merger consideration (such as new shares issued under a swap ratio). Setting a record date indicates that the merger scheme has received necessary approvals and is now moving into its execution phase. Shareholders holding shares on or before this date will be entitled to the merger benefits.

Likely market impact

Existing shareholders should hold their shares until the record date to be eligible for any share swap or consideration under the merger scheme. The announcement confirms the merger is progressing as planned and is close to completion.